Some vendor and storage guides mention wider windows such as 3-6 weeks, but that does not mean every vial should be pushed to the longest possible date
Use in Sports Injuries : Athletes have reported significant benefits, including faster recovery from serious injuries such as tendon ruptures, thereby enhancing their return to performance 4
The clinical development program was discontinued after reaching phase II trials
TB-500 and Thymosin Beta-4 are also prohibited by WADA/USADA under S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), applicable at all times both in-competition and out-of-competition TB-500 / Thymosin Beta-4 Clinical Trials: The RGN-352 and RGN-259 Programs RegeneRx Biopharmaceuticals has pursued two clinical development programs for Thymosin Beta-4, providing the most substantial human clinical data available for any TB-500-related compound: RGN-352 (Injectable Thymosin Beta-4 for Cardiac Repair): Phase 1 trial (completed): A double-blind, placebo-controlled study enrolled 40 healthy volunteers across four cohorts of 10 subjects each, testing escalating dose levels of intravenous Thymosin Beta-4 administered daily over 14 days
Thats why its often considered during: Sports injuries Ligament or tendon strains Post-surgical recovery Some practitioners use it for gut-related concerns since it was originally studied in relation to stomach lining protection